By Kate Sheridan 11/29/18
In many ways, the pitch night in Kendall Square on Wednesday was business as usual. Founders presented their young biopharma and medical device companies to investors, promising they could someday take away people’s pain, capture markets — even save lives. Read more…
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
